Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …

A growing body of evidence suggests that inflammation, mitochondrial dysfunction and
oxidant-antioxidant imbalance may play a significant role in the development and …

Depression is less prevalent among older adults than among younger adults, but it can have
serious consequences. More than half of cases represent a first onset in later life. Although …

Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …

Depressive disturbances are common in patients with Parkinson's disease (PD) and
influence many other clinical aspects of the disease. In addition to causing inherent …

This study was undertaken to determine the prevalence and correlates of cognitive
impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with …

Background Parkinson's disease (PD) is the second most prevalent neurodegenerative
disorder in the world. In addition to motor symptoms, a variety of non-motor symptoms …

Enormous progress has been made in the treatment of Parkinson's disease (PD). As a result
of advances in experimental therapeutics, many promising therapies for PD are emerging …

Background: Parkinson disease (PD) is a common neurodegenerative disease affecting up
to 1 million individuals in the United States. Depression affects up to 50% of these patients …

Objective To determine whether, for patients with depression and Parkinson disease (PD),
telephone-based cognitive-behavioral treatment (T-CBT) alleviates depressive symptoms …